Aura Biosciences, Inc. (AURA) stock forecast and price target
Price $7.11 · data as of November 13, 2026
12-month price target
Average target$16.60
Upside / downside+133.5%
Analysts5
ConsensusStrong buy
Low $12.00Average $16.60High $23.00
Gold marker: average target · white marker: today’s price ($7.11)
Analyst ratings
Strong buy 1Buy 5Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.50 | — | $0 |
| Next fiscal year ends December 31, 2027 | $-1.26 | — | $5M |
| Quarter after ends December 31, 2026 | $-0.28 | — | $0 |
Consensus of the analysts covering Aura Biosciences, updated daily. In the last 30 days 1 estimates were raised and 3 lowered.
Frequently asked questions
What is the Aura Biosciences stock price target?
The average 12-month target from 5 analysts is $16.60, 133.5% above the current price of $7.11 Targets range from $12.00 to $23.00.
Is Aura Biosciences a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 5 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Aura Biosciences expected to earn?
Analysts expect EPS of $-1.50 for the fiscal year ending December 31, 2026 and $-1.26 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.